EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation

The two essential requirements for pathologic specimens in the era of personalized therapies for non-small cell lung carcinoma (NSCLC) are accurate subtyping as adenocarcinoma (ADC) versus squamous cell carcinoma (SqCC) and suitability for EGFR molecular testing, as well as for testing of other onco...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonicelli, Alberto, Cafarotti, Stefano, Indini, Alice, Galli, Alessio, Russo, Andrea, Cesario, Alfredo, Lococo, Filippo Maria, Russo, Patrizia, Mainini, Alberto Franco, Bonifati, Luca Giuseppe, Nosotti, Mario, Santambrogio, Luigi, Margaritora, Stefano, Granone, Pierluigi Maria, Dutly, André Emanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575628/
https://www.ncbi.nlm.nih.gov/pubmed/23423768
http://dx.doi.org/10.7150/ijms.4609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575628/
https://www.ncbi.nlm.nih.gov/pubmed/23423768
http://dx.doi.org/10.7150/ijms.4609

Ejemplares similares